Archives for March 2007
Oxygen-concentrating Wound Dressing Delivers A Breath Of Fresh Air To Hard-to Heal Wounds
Archimed, a Bedford (UK) based biotechnology firm, has today announced the launch of a new range of oxygen-concentrating hydrogel wound dressings - Oxyzyme™ - that transfer dissolved oxygen to the surface of hard-to-heal chronic wounds, such as ulcers or post-operative wounds. Oxygen is essential to life. In wound healing it plays a key role [...]
FDA Launches Web Page Warning Against Buying Accutane And Its Generic Versions Online
The U.S. Food & Drug Administration (FDA) is launching a special Web page to warn consumers about the dangers of buying isotretinoin (Accutane) online. Isotretinoin is a drug approved for the treatment of severe recalcitrant nodular acne that does not respond to antibiotics. Improperly used, isotretinoin can cause severe side effects, including birth defects. [...]
Cutera Receives FDA Clearance For Its New Laser, Pearl, Using YSGG Technology
Cutera, Inc.(R) (Nasdaq: CUTR), a leading provider of laser and other light-based aesthetic systems for practitioners worldwide, today announced FDA clearance for its new laser, Pearl, with proprietary YSGG technology. Pearl is cleared for the treatment of wrinkles and represents the first application of the 2790 nm wavelength for cosmetic dermatology. During treatment, Pearl [...]
Voices Of Scleroderma Book Series Is A Collection Of Stories To Inspire, Support, And Educate Patients And Medical Professionals
The Voices of Scleroderma book series by the nonprofit International Scleroderma Network, present intimate stories of the illness plus stellar medical information for patients and caregivers of this often life-threatening autoimmune illness. Some types of the arthritic disease scleroderma affect only the skin. [click link for full article]
Original post by Dermatology News From Medical News [...]
EPG Patient Direct Partners With Merck Serono To Produce Psoriasis Quick Guide
IMR International Limited, developers of e-communication and clinical information solutions, today announced that Merck Serono will partner with the Company to develop a new online interactive guide to psoriasis. The new resource will form part of the EMA (European Medical Association) sanctioned EPG Patient Direct, a new web service dedicated to providing patients and the [...]
Heal-Or Announces Auspicious Results in 1st Phase Clinical Trials with its Leading Product (HO-03-03) for Curing Chronic Wounds
Heal-Or, a biopharmaceutical company focused on the development of therapeutics for wound healing announced auspicious results in 1st phase clinical trials with its leading product “HO-03-03″ for curing chronic wounds in 3 medical centers in Israel. The company has recently begun the regulatory practice necessary for receiving FDA approval to conduct clinical trials in the [...]
Heal-Or Announces Auspicious Results Of Clinical Trials With Its Leading Product (HO-03-03) For Curing Chronic Wounds - Israel
Heal-Or, an Israeli biopharmaceutical company focused on the development of therapeutics for wound healing and various skin disorders announces auspicious results of phase I clinical trials with its leading product “HO-03-03″ for curing chronic wounds, that are currently conducted in 3 medical centers in Israel. The company has recently begun the regulatory practice necessary for [...]
Research Promises New Wound-healing Materials That Start Out As Liquids And Fill In Gaps Between Damaged Or Missing Tissue, And Then Harden
Researchers are developing scaffoldlike materials designed to be injected into the body where they will quickly solidify to fit any space, repairing damaged bones, spinal cords, arteries and other tissues. [click link for full article]
Original post by Dermatology News From Medical News Today
New Angle To Treat Hard-To-Reach Acne
There is a new angle of attack on body acne in places that are hard-to-reach and treat, such as the back. ClindaReach™, a revolutionary easy to use treatment that packages a topical antibiotic with an ergonomically designed applicator to treat hard-to-reach acne, was launched this week by DUSA Pharmaceuticals, Inc. (NASDAQ GM: DUSA). [click [...]
GlaxoSmithKline Announces Altargo® Receives Positive Opinion In Europe For Treatment Of Impetigo And Other Skin Infections
GlaxoSmithKline (GSK) today announced that its new, novel topical antibiotic ALTARGO® (retapamulin ointment, 1%) received a positive opinion from the European Committee for Human Medicinal Products (CHMP) for the treatment of impetigo and infected small lacerations, abrasions or sutured wounds. Impetigo is a superficial skin infection most commonly seen in children. The CHMP’s positive opinion [...]